Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
11/2000
11/02/2000EP1047685A1 Substituted beta,gamma-anellated lactones
11/02/2000EP1047684A1 Substituted alpha,beta-anellated butyrolactones
11/02/2000EP1047683A1 Thioether furan nitrone compounds
11/02/2000EP1047676A1 Substituted 11-phenyl-dibenzazepine compounds useful for the treatment or prevention of diseases characterized by abnormal cell proliferation
11/02/2000EP1047675A1 Chemokine receptor antagonists and methods of use therefor
11/02/2000EP1047670A1 Aminosulphonylbenzamide derivatives as modulators of the activity of neuronal calcium channels
11/02/2000EP1047668A1 Triazepinones, process for their preparation and their therapeutic application
11/02/2000EP1047665A1 Matrix metalloprotease inhibitors
11/02/2000EP1047664A1 Novel tricyclic compounds, preparation method and pharmaceutical compositions containing same
11/02/2000EP1047656A1 Alkenyldiarylmethane non-nucleoside hiv-1 reverse transcriptase inhibitors
11/02/2000EP1047450A1 Ace inhibitor-mmp inhibitor combinations
11/02/2000EP1047449A1 Immunological compositions and methods of use to transiently alter mammalian central nervous system myelin to promote neuronal regeneration
11/02/2000EP1047441A1 Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation
11/02/2000EP1047437A1 Sea cucumber carotenoid lipid fraction products and methods of use
11/02/2000EP1047436A2 Methods of treating tardive dyskinesia and other movement disorders
11/02/2000EP1047425A1 Integrin receptor antagonists
11/02/2000EP1047424A1 Il-8 receptor antagonists
11/02/2000EP1047422A1 Use of histamine for elevating blood histamine levels
11/02/2000EP1047421A2 Inhibition of lipoprotein oxidation
11/02/2000EP1047418A1 Inhibition of raf kinase using substituted heterocyclic ureas
11/02/2000EP1047416A2 Pharmaceutical compositions comprising disulfiram for inhibiting angiogenesis
11/02/2000EP0808312B1 Indole derivatives as 5-ht receptor antagonist
11/02/2000DE19917990A1 Arzneimittel enthaltend Hemmstoffe der zellvolumenregulierten humanen Kinase h-sgk Medicines containing inhibitors of cell volume-regulated human kinase h-sgk
11/02/2000CA2377135A1 Dsp-10 dual-specificity map kinsase phosphatase
11/02/2000CA2371662A1 Peptide homodimers and peptide heterodimers, derived from interferon .alpha.2
11/02/2000CA2371308A1 Tri-aryl acid derivatives as ppar receptor ligands
11/02/2000CA2371274A1 Selective npy (y5) antagonists
11/02/2000CA2371241A1 Tgf-.alpha. polypeptides, functional fragments and methods of use therefor
11/02/2000CA2371217A1 A pharmaceutical formulation containing an inhibitor of carboxypeptidase u and a thrombin inhibitor
11/02/2000CA2371165A1 Vitamin d analogues and their pharmaceutical use
11/02/2000CA2371008A1 A pharmaceutical formulation comprising a low molecular weight thrombin inhibitor and its prodrug
11/02/2000CA2370590A1 Agent for suppressing the odors of sulfides formed through fermentation in the large intestine
11/02/2000CA2370576A1 Novel anticoagulant injectable composition
11/02/2000CA2370547A1 Dsp-5 dual-specificity map kinase phosphatase
11/02/2000CA2370306A1 Treatment of fibrosis by antagonism of il-13 and il-13 receptor chains
11/02/2000CA2370286A1 A ligand of the protein "beacon"
11/02/2000CA2370264A1 5-pyridyl-1,3-azole compounds, process for producing the same and use thereof
11/02/2000CA2370241A1 Tetrahydroisoquinolinyl-indole derivatives for the treatment of depression
11/02/2000CA2370195A1 Human membrane-associated proteins
11/02/2000CA2369910A1 Compositions and methods for treatment of hyperproliferative diseases
11/02/2000CA2369579A1 Controlled release of growth factors from heparin containing matrices
11/02/2000CA2369109A1 Thrombin inhibitors
11/02/2000CA2369092A1 Heterosubstituted pyridine derivatives as pde 4 inhibitors
11/02/2000CA2368213A1 Specifically targeted catalytic antagonists and uses thereof
11/02/2000CA2367750A1 Tribonectins
11/02/2000CA2367682A1 Tetracyclic azepinoindole compounds as 5-ht receptor ligands
11/01/2000CN1272111A Tricyclic vasopressin agonists
11/01/2000CN1272110A Tricyclic vasopressin agonists
11/01/2000CN1272107A Benzamidine derivatives as factor Xa inhibitors
11/01/2000CN1272105A Compound containing six-membered rings, processes for their preparation, and their use as medicaments
11/01/2000CN1272060A Use of sulfated oligosaccharides as inhibitors of cardiovascular disease
11/01/2000CN1271734A Substituted 19-norsteroid, its preparation and intermediate and its medical use and composition
11/01/2000CN1271731A New thiazole benzimidazole derivative
11/01/2000CN1058021C New peptides derived from trifluorumethylketones, process for their preparation and pharmaceutical compositions which contain them
11/01/2000CN1058020C Angiotensin converting enzyme inhibitor and method for preparing same
11/01/2000CN1058016C Sulphuric acid esters of amino-sugars, its salt for medicine, preparing process and use
11/01/2000CN1058014C New heterocyclic spiro compounds, process for preparation thereof, and pharmaceutical compositions containing them
11/01/2000CN1058013C Process for preparation of novel mercaptoacetylamide derivatives
11/01/2000CN1058008C Phenyl heterocycles as cyclooxygenase-2 inhibitors
11/01/2000CN1058004C Heterocyclo-benzoylguanidin
11/01/2000CN1058001C 4-Mercaptobenzoylguanidine derivatives
11/01/2000CN1057937C Use of lysozyme dimer and preparations containing same
11/01/2000CN1057931C Method for removing phenolic acid from ginkgo leaf extract by supercritical carbon dioxide
11/01/2000CN1057923C Tonic medicine
11/01/2000CN1057916C Nourishing liquid for preserving vigour
11/01/2000CN1057908C Use of hyaluronic acid and forms to prevent arterial restenosis
10/2000
10/31/2000US6140505 Synthesis of benzo fused heterocyclic sulfonyl chlorides
10/31/2000US6140488 Ras-binding protein (PRE1)
10/31/2000US6140466 Comprises at least three zinc finger domains that bind to target cellular nucleotide sequence and modulate its transcription; genome-specific transcriptional switches in gene therapy; transgenic plants and animals
10/31/2000US6140372 Acyl derivatives of melatonin and of melatoninergic analogues and their use as medicinal products
10/31/2000US6140363 Administering rosmarinic acid, its derivative or prunella vulgaris extract for suppressing immune response for treatment, prevention, or diagnosis of rejection of transplanted organ or tissue, chronic rejection
10/31/2000US6140362 Method for inhibiting the growth of mammalian cells
10/31/2000US6140357 Small molecule inhibitors of rotamase enzyme activity
10/31/2000US6140354 N-substituted aminotetralins as ligands for the neuropeptide Y Y5 receptor useful in the treatment of obesity and other disorders
10/31/2000US6140353 Used as medicaments for the treatment and/or prevention of thromboses, apoplexy, cardiac infarction, inflammation and arteriosclerosis or as antitumor agents
10/31/2000US6140352 Carbazolyl-substituted ethanolamines as selective β-3 agonists
10/31/2000US6140344 For treating pathological conditions such as asthma, rhinitis, eczema and parasitic infections featuring tissue eosinophilia
10/31/2000US6140342 Cholesteryl ester transfer protein inhibitor; used to elevate certain plasma lipid levels, including high density lipoprotein-cholesterol and to lower certain other plasma lipid levels, such as ldl-cholesterol and triglycerides
10/31/2000US6140341 For treating pain
10/31/2000US6140335 Use of mizolastine for treating inflammatory diseases associated with 5-lipoxygenase
10/31/2000US6140332 Pyrrolopyrimidines and processes for the preparation thereof
10/31/2000US6140321 Polymorphs of donepezil hydrochloride and process for production
10/31/2000US6140319 Administering an vasopeptidase inhibitor for treating and/or relieving the symptoms of angina pectoris
10/31/2000US6140317 Pyrrolopyrimidines and processes for their preparation
10/31/2000US6140313 Butyric esters with antiproliferative activity and the pharmaceutical compositions containing them
10/31/2000US6140124 Nucleotide sequences which target untranslated regions, translation start site and translation termination position; for diagnosis and treatment of tumors, inflammation and arthritis; antitumor agents; inflammatory agents
10/31/2000US6140093 Nucleotide sequences coding an enzymatic protein for use as an antidote in organophorphous insecticide poisoning and to prevent neuronal cell
10/31/2000US6140081 Nucleotide binding polypeptide; for efficient use as diagnostic tools in gene therapy and transgenic cells
10/31/2000US6140073 Useful in the promotion of tissue repair
10/31/2000US6139863 Suppositories
10/31/2000US6139860 Method of stimulating cilia
10/31/2000US6138680 Method for destroying retinal pigment epithelial cells
10/31/2000CA2185112C Humanized monoclonal antibodies against human interleukin-4
10/31/2000CA2182004C Film coated tablet of paracetamol and domperidone
10/31/2000CA2142879C Method of treating cell damage or depletion
10/27/2000CA2307022A1 Agent for enhancing cerebral acetylcholine release
10/26/2000WO2000063702A1 Peptide epitopes recognized by disease promoting cd4+ t lymphocytes
10/26/2000WO2000063430A1 Diagnosis of a person's risk for developing atherosclerosis or diabetic retinopathy
10/26/2000WO2000063396A1 Method for enhancing myoblast migration and invasion in the context of gene therapy
10/26/2000WO2000063380A1 Vascular endothelial cell growth factor variants and uses thereof
1 ... 1118 1119 1120 1121 1122 1123 1124 1125 1126 1127 1128 1129 1130 1131 1132 1133 1134 1135 1136 1137 1138 ... 1564